IRIS
CONSOLI, Agostino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.105
AS - Asia 8.315
EU - Europa 8.036
SA - Sud America 1.052
AF - Africa 147
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 10
Totale 29.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.869
SG - Singapore 3.239
CN - Cina 2.356
IT - Italia 1.269
UA - Ucraina 1.192
IE - Irlanda 1.123
RU - Federazione Russa 969
TR - Turchia 952
BR - Brasile 840
GB - Regno Unito 823
SE - Svezia 775
FR - Francia 726
VN - Vietnam 662
DE - Germania 542
IN - India 344
FI - Finlandia 280
BD - Bangladesh 191
HK - Hong Kong 144
CA - Canada 125
AR - Argentina 77
PL - Polonia 72
MX - Messico 66
KR - Corea 65
NL - Olanda 63
JP - Giappone 58
IQ - Iraq 49
EC - Ecuador 46
ZA - Sudafrica 46
ES - Italia 40
ID - Indonesia 39
CZ - Repubblica Ceca 30
BE - Belgio 28
AT - Austria 25
EG - Egitto 23
PK - Pakistan 23
PH - Filippine 22
CL - Cile 21
CO - Colombia 20
SA - Arabia Saudita 20
IL - Israele 19
MA - Marocco 17
EU - Europa 16
LT - Lituania 16
VE - Venezuela 15
KE - Kenya 14
MY - Malesia 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
UZ - Uzbekistan 13
JO - Giordania 12
PY - Paraguay 12
RO - Romania 12
IR - Iran 10
PE - Perù 10
AU - Australia 9
BG - Bulgaria 9
CH - Svizzera 9
ET - Etiopia 9
HN - Honduras 9
KZ - Kazakistan 9
NP - Nepal 8
PT - Portogallo 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
AL - Albania 6
BO - Bolivia 6
CR - Costa Rica 6
TW - Taiwan 6
BH - Bahrain 5
GT - Guatemala 5
OM - Oman 5
SN - Senegal 5
UY - Uruguay 5
GR - Grecia 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
TH - Thailandia 4
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
AM - Armenia 2
BB - Barbados 2
BS - Bahamas 2
DK - Danimarca 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MN - Mongolia 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
Totale 29.664
Salva come PNG Salva come JPEG
Città #
Singapore 2.259
San Jose 1.468
Jacksonville 1.358
Chandler 1.297
Dublin 1.115
Ashburn 781
Southend 556
Dallas 552
Princeton 538
Beijing 509
Izmir 499
Nanjing 383
Dearborn 376
Los Angeles 344
Council Bluffs 299
Wilmington 253
Cambridge 222
Santa Clara 209
Ho Chi Minh City 206
Tongling 188
The Dalles 163
Buffalo 162
Hanoi 158
New York 154
Nanchang 148
Ann Arbor 145
Altamura 140
Moscow 134
Hong Kong 130
Boardman 118
Pescara 113
Chieti 99
Shenyang 99
São Paulo 92
Woodbridge 91
Rome 85
Munich 74
Hebei 68
Kunming 64
Milan 63
Brooklyn 62
Grevenbroich 61
Tianjin 61
Jiaxing 56
Washington 55
Hefei 52
Norwalk 52
Tokyo 52
Warsaw 48
Frankfurt am Main 47
Redondo Beach 47
Seoul 46
Chicago 41
Changsha 40
Orem 40
London 39
Hangzhou 37
Denver 36
Helsinki 36
Chennai 35
Houston 34
San Francisco 33
Toronto 33
Montreal 32
Ningbo 32
Atlanta 31
Cedar Knolls 31
Haiphong 29
Nuremberg 29
Johannesburg 28
Falls Church 27
Orange 27
Rio de Janeiro 27
Jinan 26
Stockholm 25
Mexico City 24
Phoenix 24
Boston 23
Brussels 23
Dong Ket 23
Guangzhou 23
Brno 22
Manchester 22
Naples 22
Poplar 22
Da Nang 21
Biên Hòa 19
San Mateo 19
Amsterdam 18
Turku 18
Augusta 17
Mumbai 17
Quito 17
Ankara 16
Belo Horizonte 16
Changchun 16
Florence 16
Leawood 16
Istanbul 15
Lappeenranta 15
Totale 17.583
Salva come PNG Salva come JPEG
Nome #
Policaptil Gel Retard® reduces body weight and improves insulin sensitivity in obese subjects 278
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 244
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6 222
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 204
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 196
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 192
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 190
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 182
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 180
Principi di Endocrinologia 179
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 177
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 173
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 169
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 160
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 159
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 158
Assorbimento dell’insulina umana semisintetica dopo iniezione sottocutanea a spruzzo transcutaneo mediante iniettore 158
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 158
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 157
Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity 156
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 156
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 155
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 153
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 152
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 152
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment 149
Difetti Beta cellulari nel diabete di tipo 2 149
Preliminari esperienze terapeutiche del diabete in gravidanza 143
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 143
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 142
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy 142
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 141
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 141
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 141
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 140
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 140
Treatment of unstable diabetes by continuous subcutaneous infusion of insulin. 140
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 140
A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes 139
Cigarette smoke, ferritin, and lipid peroxidation 139
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 138
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 138
Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. 137
Myoinositol reduces inflammation and oxidative stress in human endothelial cells exposed in vivo to chronic hyperglycemia 137
Valutazione del fabbisogno insulinico post-prandiale in pazienti diabetici trattati con microinfusore insulinico 136
Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon 136
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 136
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 135
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 135
Heightened free radical activity in angina pectoris 135
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 135
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 135
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 135
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 134
Endocrinologia Clinica 134
DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. 134
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 133
Post-prandial requirement and composition of the diet. Study on type I diabetics treated with infuser 132
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 131
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 131
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes 131
Ottimizzazione della terapia con insulina basale nel DM2: add-on di GLP-1 RA in associazione libera e in combinazione pre-costituita 131
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 130
Effects of a "single-meal" low calorie diet on the circadian variation of serum cortisol, insulin and somatotropin and urinary excretion of catecholamines. 130
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 130
Liraglutide and cardiovascular outcomes in type 2 diabetes 130
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 129
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 128
Administration of semisynthetic human insulin by a spray injector 128
Variations in carbohydrate, lipid and protein oxidation evaluated by indirect calorimetry in obese subjects on a "single-meal" low-calorie diet. 128
Teleretinography into diabetes integrated care: an Italian experience 128
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 127
Acute hyperinsulinemia decreases plasma fibrinolytic activity in the rat 127
Il sintomo impotenza come esordio di una neuropatia diabetica nel paziente di sesso maschile 126
Valutazione dell’efficacia delle prestazioni nel servizio di diabetologia: impatto dell’emoglobina glicata 126
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type 2 diabetic subjects 125
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 125
The dawn phenomenon in Type I (insulin-dependent) diabetic patient treated by continuous subcutaneous insulin infusion. 124
La terapia insulinica: tradizione e novità 124
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 124
Le terapie incretiniche e l'approccio clinico multifattoriale del paziente cardiometabolico 124
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 124
La dieta ipocalorica nella terapia del diabete di tipo 2 con obesità. Confronto con dieta ipo- e normoglicidica a differente contenuto calorico. 123
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 123
Soluble RAGE in type 2 diabetes: association with oxidative stress. 122
The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. 122
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 122
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 121
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 120
Coagulation of hexokinase II and glycogen synthase RNA, protein, and activity in human muscle 119
Determinanti del controllo metabolico in pazienti con diabete di tipo I in terapia insulinica intensiva 119
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 119
Treatment of brittle diabetes by continuous subcutaneous in-insulin infusion. Comparison with conventional treatment 118
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 118
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 118
Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data. 117
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 116
I glitazoni 116
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? 116
Totale 14.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.200 29 33 2 247 93 19 50 79 107 36 157 348
2022/20233.707 325 403 196 435 324 758 233 288 493 54 116 82
2023/20241.883 111 61 135 69 74 497 474 78 26 79 63 216
2024/20254.409 336 694 507 99 94 138 159 277 571 186 463 885
2025/202610.004 770 507 1.069 1.146 848 608 1.513 654 1.149 869 543 328
2026/2027329 329 0 0 0 0 0 0 0 0 0 0 0
Totale 30.642